195 related articles for article (PubMed ID: 36793210)
1. Comparative analysis of CRISPR off-target discovery tools following ex vivo editing of CD34
Cromer MK; Majeti KR; Rettig GR; Murugan K; Kurgan GL; Bode NM; Hampton JP; Vakulskas CA; Behlke MA; Porteus MH
Mol Ther; 2023 Apr; 31(4):1074-1087. PubMed ID: 36793210
[TBL] [Abstract][Full Text] [Related]
2. Ultra-deep sequencing validates safety of CRISPR/Cas9 genome editing in human hematopoietic stem and progenitor cells.
Cromer MK; Barsan VV; Jaeger E; Wang M; Hampton JP; Chen F; Kennedy D; Xiao J; Khrebtukova I; Granat A; Truong T; Porteus MH
Nat Commun; 2022 Aug; 13(1):4724. PubMed ID: 35953477
[TBL] [Abstract][Full Text] [Related]
3. Identification and Validation of CRISPR/Cas9 Off-Target Activity in Hematopoietic Stem and Progenitor Cells.
Park SH; Lee CM; Bao G
Methods Mol Biol; 2022; 2429():281-306. PubMed ID: 35507169
[TBL] [Abstract][Full Text] [Related]
4. Chemical Modification of Guide RNAs for Improved CRISPR Activity in CD34+ Human Hematopoietic Stem and Progenitor Cells.
Shapiro J; Tovin A; Iancu O; Allen D; Hendel A
Methods Mol Biol; 2021; 2162():37-48. PubMed ID: 32926376
[TBL] [Abstract][Full Text] [Related]
5. Prediction and validation of hematopoietic stem and progenitor cell off-target editing in transplanted rhesus macaques.
AlJanahi AA; Lazzarotto CR; Chen S; Shin TH; Cordes S; Fan X; Jabara I; Zhou Y; Young DJ; Lee BC; Yu KR; Li Y; Toms B; Tunc I; Hong SG; Truitt LL; Klermund J; Andrieux G; Kim MY; Cathomen T; Gill S; Tsai SQ; Dunbar CE
Mol Ther; 2022 Jan; 30(1):209-222. PubMed ID: 34174439
[TBL] [Abstract][Full Text] [Related]
6. Guide Swap enables genome-scale pooled CRISPR-Cas9 screening in human primary cells.
Ting PY; Parker AE; Lee JS; Trussell C; Sharif O; Luna F; Federe G; Barnes SW; Walker JR; Vance J; Gao MY; Klock HE; Clarkson S; Russ C; Miraglia LJ; Cooke MP; Boitano AE; McNamara P; Lamb J; Schmedt C; Snead JL
Nat Methods; 2018 Nov; 15(11):941-946. PubMed ID: 30297964
[TBL] [Abstract][Full Text] [Related]
7. Optimized Guide RNA Selection Improves
Verhagen HJMP; Kuijk C; Rutgers L; Kokke AM; van der Meulen SA; van Mierlo G; Voermans C; van den Akker E
CRISPR J; 2022 Oct; 5(5):702-716. PubMed ID: 36169633
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of CRISPR gene-editing tools in zebrafish.
Uribe-Salazar JM; Kaya G; Sekar A; Weyenberg K; Ingamells C; Dennis MY
BMC Genomics; 2022 Jan; 23(1):12. PubMed ID: 34986794
[TBL] [Abstract][Full Text] [Related]
9. Genome Editing in Zebrafish Using High-Fidelity Cas9 Nucleases: Choosing the Right Nuclease for the Task.
Prykhozhij SV; Cordeiro-Santanach A; Caceres L; Berman JN
Methods Mol Biol; 2020; 2115():385-405. PubMed ID: 32006412
[TBL] [Abstract][Full Text] [Related]
10. Optimization of CRISPR/Cas9 Delivery to Human Hematopoietic Stem and Progenitor Cells for Therapeutic Genomic Rearrangements.
Lattanzi A; Meneghini V; Pavani G; Amor F; Ramadier S; Felix T; Antoniani C; Masson C; Alibeu O; Lee C; Porteus MH; Bao G; Amendola M; Mavilio F; Miccio A
Mol Ther; 2019 Jan; 27(1):137-150. PubMed ID: 30424953
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Homology-Independent CRISPR-Cas9 Off-Target Assessment Methods.
Chaudhari HG; Penterman J; Whitton HJ; Spencer SJ; Flanagan N; Lei Zhang MC; Huang E; Khedkar AS; Toomey JM; Shearer CA; Needham AW; Ho TW; Kulman JD; Cradick TJ; Kernytsky A
CRISPR J; 2020 Dec; 3(6):440-453. PubMed ID: 33346710
[TBL] [Abstract][Full Text] [Related]
12. TEG-seq: an ion torrent-adapted NGS workflow for in cellulo mapping of CRISPR specificity.
Tang PZ; Ding B; Peng L; Mozhayskiy V; Potter J; Chesnut JD
Biotechniques; 2018 Nov; 65(5):259-267. PubMed ID: 30114933
[TBL] [Abstract][Full Text] [Related]
13. Amplification-free long-read sequencing reveals unforeseen CRISPR-Cas9 off-target activity.
Höijer I; Johansson J; Gudmundsson S; Chin CS; Bunikis I; Häggqvist S; Emmanouilidou A; Wilbe M; den Hoed M; Bondeson ML; Feuk L; Gyllensten U; Ameur A
Genome Biol; 2020 Dec; 21(1):290. PubMed ID: 33261648
[TBL] [Abstract][Full Text] [Related]
14. Unbiased detection of CRISPR off-targets in vivo using DISCOVER-Seq.
Wienert B; Wyman SK; Richardson CD; Yeh CD; Akcakaya P; Porritt MJ; Morlock M; Vu JT; Kazane KR; Watry HL; Judge LM; Conklin BR; Maresca M; Corn JE
Science; 2019 Apr; 364(6437):286-289. PubMed ID: 31000663
[TBL] [Abstract][Full Text] [Related]
15. Genome editing in human hematopoietic stem and progenitor cells via CRISPR-Cas9-mediated homology-independent targeted integration.
Bloomer H; Smith RH; Hakami W; Larochelle A
Mol Ther; 2021 Apr; 29(4):1611-1624. PubMed ID: 33309880
[TBL] [Abstract][Full Text] [Related]
16. WheatCRISPR: a web-based guide RNA design tool for CRISPR/Cas9-mediated genome editing in wheat.
Cram D; Kulkarni M; Buchwaldt M; Rajagopalan N; Bhowmik P; Rozwadowski K; Parkin IAP; Sharpe AG; Kagale S
BMC Plant Biol; 2019 Nov; 19(1):474. PubMed ID: 31694550
[TBL] [Abstract][Full Text] [Related]
17. Activities and specificities of CRISPR/Cas9 and Cas12a nucleases for targeted mutagenesis in maize.
Lee K; Zhang Y; Kleinstiver BP; Guo JA; Aryee MJ; Miller J; Malzahn A; Zarecor S; Lawrence-Dill CJ; Joung JK; Qi Y; Wang K
Plant Biotechnol J; 2019 Feb; 17(2):362-372. PubMed ID: 29972722
[TBL] [Abstract][Full Text] [Related]
18. Doxycycline-Dependent Self-Inactivation of CRISPR-Cas9 to Temporally Regulate On- and Off-Target Editing.
Kelkar A; Zhu Y; Groth T; Stolfa G; Stablewski AB; Singhi N; Nemeth M; Neelamegham S
Mol Ther; 2020 Jan; 28(1):29-41. PubMed ID: 31601489
[TBL] [Abstract][Full Text] [Related]
19. A Versatile Tool for the Quantification of CRISPR/Cas9-Induced Genome Editing Events in Human Hematopoietic Cell Lines and Hematopoietic Stem/Progenitor Cells.
Jayavaradhan R; Pillis DM; Malik P
J Mol Biol; 2019 Jan; 431(1):102-110. PubMed ID: 29751014
[TBL] [Abstract][Full Text] [Related]
20. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
